A multicenter, Phase II trial of weekly
✍
Mace L. Rothenberg; John V. Cox; Russell F. DeVore; John D. Hainsworth; Richard
📂
Article
📅
1999
🏛
John Wiley and Sons
🌐
English
⚖ 110 KB
👁 2 views
## Background: This multicenter, phase ii trial was performed to evaluate the antitumor activity and toxicity of irinotecan (cpt-11) in patients with metastatic colorectal carcinoma that had recurred or progressed after 5-fluorouracil (5-fu)-based chemotherapy. ## Methods: Cpt-11 was given as a 9